John E. Kao Sells 90,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 90,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $14.84, for a total value of $1,335,600.00. Following the completion of the sale, the chief executive officer now owns 1,913,100 shares of the company’s stock, valued at $28,390,404. The trade was a 4.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Alignment Healthcare Trading Down 0.1%

Shares of ALHC opened at $14.90 on Friday. The stock has a fifty day moving average price of $17.30 and a two-hundred day moving average price of $14.53. The company has a market cap of $2.95 billion, a price-to-earnings ratio of -19.35 and a beta of 1.32. Alignment Healthcare, Inc. has a 52-week low of $6.82 and a 52-week high of $21.06. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.07. The company had revenue of $926.93 million during the quarter, compared to analysts’ expectations of $889.83 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business’s revenue for the quarter was up 47.5% on a year-over-year basis. During the same period last year, the firm earned ($0.25) EPS. Analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors have recently made changes to their positions in the stock. MCF Advisors LLC grew its stake in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock worth $40,000 after purchasing an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Alignment Healthcare during the first quarter worth $42,000. R Squared Ltd acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth $55,000. Amalgamated Bank grew its stake in shares of Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after purchasing an additional 616 shares during the period. Finally, RiverPark Advisors LLC acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth $106,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently issued reports on ALHC. Barclays increased their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research note on Friday, February 28th. UBS Group increased their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the company a “neutral” rating in a report on Friday, May 2nd. Stephens reissued an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. Piper Sandler raised their target price on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, March 4th. Finally, Stifel Nicolaus raised their target price on Alignment Healthcare from $18.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $17.17.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.